# From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?

**Authors:** Lukas Pillong, Caroline Burgard, Florian Rosar, Betül Demirkol, Rafail Ebner, Maximilian Linxweiler, Alessandro Bozzato, Bernhard Schick, Silke Wemmert

PMC · DOI: 10.1007/s00259-025-07468-9 · European Journal of Nuclear Medicine and Molecular Imaging · 2025-07-22

## TL;DR

This study shows that FAP is expressed in juvenile angiofibroma, suggesting FAPI-PET/CT imaging could help diagnose and guide treatment for this rare tumor.

## Contribution

First study to demonstrate FAP expression in juvenile angiofibroma and validate it with FAPI-PET/CT imaging.

## Key findings

- FAP, Vimentin, and PECAM1/CD31 were consistently expressed in juvenile angiofibroma samples.
- FAPI-PET/CT imaging accurately reflected FAP expression patterns in the tumor.
- FAP expression varied significantly within and between tumors, indicating heterogeneity.

## Abstract

Juvenile angiofibroma (JA) is a rare, benign fibrovascular tumor that predominantly affects adolescent males. The underlying biological mechanisms remain poorly understood. Fibroblast activation protein (FAP), known for its involvement in tumor invasion, matrix remodeling, and angiogenesis, has been implicated in various malignancies but has not been studied in JA so far.

We investigated FAP expression in JA samples (N = 19) using real-time (RT)-PCR (N = 10) and immunohistochemistry (N = 18). In addition, Vimentin and PECAM1/CD31 were analyzed to further characterize the tumor microenvironment. For one patient, preoperative FAPI-PET/CT imaging was conducted, and FAP expression was correlated with radiotracer uptake. Postoperative histopathological analyses of the excised tumor were performed to validate the imaging findings.

We found consistent expression of FAP, Vimentin and PECAM1/CD31 in all JA analyzed by RT-PCR. Moreover, substantial intra-and intertumor heterogeneity in FAP protein expression was observed, ranging from negative up to strong positive areas. Vimentin and PECAM1/CD31 showed variable expression patterns consistent with the fibrovascular character of JA. FAPI-PET/CT imaging accurately identified the tumor, with radiotracer uptake closely matching the distribution of FAP expression observed histologically.

This study is the first demonstrating FAP expression in JA and validating its occurrence using FAPI-PET/CT imaging. The strong correlation between FAP expression and radiotracer uptake in FAPI-PET/CT highlights the potential of this imaging modality as a non-invasive diagnostic tool. This will improve diagnosis and is the basis for further investigations of FAP-targeted therapies for JA treatment.

The online version contains supplementary material available at 10.1007/s00259-025-07468-9.

## Linked entities

- **Genes:** FAP (fibroblast activation protein alpha) [NCBI Gene 2191], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175]

## Full-text entities

- **Genes:** PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, VIM (vimentin) [NCBI Gene 7431], FAP (fibroblast activation protein alpha) [NCBI Gene 2191] {aka DPPIV, FAPA, FAPalpha, SIMP}
- **Diseases:** benign fibrovascular tumor (MESH:D009369), JA (MESH:D018322)
- **Chemicals:** FAPI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12830413/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12830413/full.md

---
Source: https://tomesphere.com/paper/PMC12830413